share_log

Bellerophon Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Puissance Life Science Opportunities Fund VI

SEC announcement ·  Jun 7, 2023 21:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more